November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
According to market projections, the DNA vaccine sector is expected to grow from USD 553.89 million in 2024 to USD 1041.68 million by 2034, reflecting a CAGR of 6.52%. In 2024, North America led the global DNA vaccine market, with Asia-Pacific expected to grow fastest. Oncept dominated by product type, while Apex-IHN is set for notable growth....
November 01, 2025
Market insights predict the global U.S. healthcare ERP industry will increase from USD 2.17 billion in 2024 to USD 3.83 billion by 2034, achieving a CAGR of 5.84%. In 2024, finance & billing led the U.S. healthcare ERP market, while inventory & material management is set for rapid growth. On-premises deployment dominated, but cloud solution...
November 01, 2025
According to market projections, the global cannabidiol market, valued at USD 8.97 billion in 2024, is anticipated to reach USD 38.97 billion by 2034, growing at a CAGR of 15.83% over the next decade. In 2024, North America dominated the cannabidiol market with an 88% share, while Europe is set for the fastest growth. Hemp was the top source and is...
November 01, 2025
Projections indicate that, the global anti-obesity drugs market will increase from USD 7.17 billion in 2024 to USD 78.46 billion by 2034, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, with Asia Pacific set for the fastest growth. Prescription drugs dominated, while OTC drugs are pois...
November 01, 2025
Based on market forecasts, the renewable/sustainable laboratory plasticware sector will expand from USD 0.42 billion in 2024 to USD 2.40 billion by 2034, experiencing a CAGR of 19.03%. In 2024, Europe led the renewable lab plasticware market, with bioplastics dominating by type. The polypropylene segment was the largest polymer, while pipette tips ...
November 01, 2025
Projections indicate that, companion animal health industry is projected to rise from USD 25.28 billion in 2024 to USD 61.74 billion by 2034, reflecting a CAGR of 9.34% over the next decade. In 2024, North America led the companion animal health market, with dogs dominating by animal type. Pharmaceuticals were the top product, and hospital pharmaci...
November 01, 2025
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory disease treatment market, with antibiotic therapy, oral administration, adult women, and hospitals as d...
November 01, 2025
Market insights predict the global cervical cancer treatment industry will increase from USD 8.65 billion in 2024 to USD 14.68 billion by 2034, achieving a CAGR of 5.44%. In 2024, North America led the cervical cancer treatment market, with Europe set for strong growth. Squamous cell carcinoma was the top type, while adenocarcinoma is expected to g...
November 01, 2025
According to market projections, the global bone marrow transplant market, valued at USD 10.75 billion in 2024, is anticipated to reach USD 16.76 billion by 2034, growing at a CAGR of 4.54% over the next decade. In 2024, North America led the bone marrow transplant market, with autologous transplants and leukemia treatments dominating. Hospitals we...
November 01, 2025
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the fastest growth. Immunosuppressants dominated treatment, while monoclonal antibodies are poised to ris...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com